Eprogen

Darien, United States Founded: 2001 • Age: 25 yrs
Develops chromatographic methods for protein analysis and biomarker discovery in proteomics.

About Eprogen

Eprogen is a Healthcare company based in Darien (United States) founded in 2001 by Tim Barder. It develops chromatographic methods for protein analysis and biomarker discovery in proteomics. It operates on a B2B and D2C model. Its chief executive, as recorded, is Tim Barder. Eprogen offers products and services including ProteoSep® 2D Proteomics, HPLC Columns, ProteoSep® Buffers, and Non-Porous Silica (NPS). Its focus areas include Health and Life Sciences, Analytical Chemistry, Chromatography and HPLC. Its legal entity is PROMIGEN LIFE SCIENCES, LLC. Similar companies include Nautilus Biotechnology, Somalogic and ProteinSimple; 3 of its 3 listed similar companies have raised funding.

Company details

Eprogen, operating as Promigen Life Sciences, LLC, is a bioanalytical chemistry company in Downers Grove, Illinois, USA. It focuses on developing tools for separating and analyzing complex protein systems using chromatographic and molecular biology techniques. Their activities include creating solutions for clinical proteomics and protein biomarker discovery, offering products like HPLC columns and ProteoSep systems to research labs and distributors.

  • Headquarters Darien, United States
  • Founders Tim Barder
  • Sectors
    Healthcare
  • Email
    ••••••••
  • Phone
    •••• ••••
  • Website eprogen.com
  • Social Facebook
  • Legal Name Promigen Life Sciences, Llc

Products & Services of Eprogen

Eprogen offers a comprehensive portfolio of products and services, including ProteoSep® 2D Proteomics, HPLC Columns, ProteoSep® Buffers, and Non-Porous Silica (NPS).

ProteoSep® 2D Proteomics
Proteomics Platform

System for protein biomarker discovery using HPLC and immunoassays

HPLC Columns
Chromatography Tools

Columns for high-resolution protein and peptide separations

ProteoSep® Buffers
Proteomics Accessories

Buffers for 2D fractionation in protein analysis

Non-Porous Silica (NPS)
Separation Materials

Materials for ultra-fast protein separations

People of Eprogen

1 people are tracked at Eprogen (1 in leadership).

NameRoleGroup
Tim Barder
Founder, CEOLeadership
Premium access

Complete people profiles for Eprogen

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Similar companies to Eprogen

Eprogen has 3 listed similar companies in our database, 3 of them funded. They include Nautilus Biotechnology, Somalogic and ProteinSimple.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
nautilus.bio2016Seattle, United States$103.26M134
A proteomics platform is developed for analyzing the human proteome.
somalogic.com1999Boulder, United States$663.99M319
Protein-based assays are developed for life science research.
proteinsimple.com2004San Jose, United States$114.29M157
Provider tools to help researchers with protein analysis
Premium access

Detailed similar companies of Eprogen

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Web traffic of Eprogen

Websites that share an audience with Eprogen (eprogen.com).

Similar websites

Websites whose visitors overlap most with Eprogen. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
alphalyse.com
83%
2.9KView details

Top companies in Toxicology

3 companies that operate in the same segment as Eprogen (Toxicology) in United States, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Therapeutic solutions for food allergies are developed via antibody platforms.
2019San Francisco, California, United StatesUSD 75 M
Therapeutics for substance use disorders, including opioid-related conditions, are developed.
2020Oakland, California, United StatesUSD 70 M
Drug delivery solutions via single-walled carbon nanotubes are offered.
2008Houston, Texas, United StatesUSD 2.5 MUSD 5.07 M9
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • ✓
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • ✓
    Full access to every database India & global coverage, advanced filters and rich profile details
  • ✓
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Eprogen

Eprogen was founded in 2001.

Eprogen is headquartered in Darien, United States. It is registered at Darien, Connecticut, United States.

Tim Barder is the CEO of Eprogen, as recorded in our data. They have also founded this company.

Eprogen, operating as Promigen Life Sciences, LLC, is a bioanalytical chemistry company in Downers Grove, Illinois, USA. It focuses on developing tools for separating and analyzing complex protein systems using chromatographic and molecular biology techniques. Their activities include creating solutions for clinical proteomics and protein biomarker discovery, offering products like HPLC columns and ProteoSep systems to research labs and distributors.

Eprogen's top competitors include Somalogic, Nautilus Biotechnology and ProteinSimple.

Eprogen offers ProteoSep® 2D Proteomics, HPLC Columns, ProteoSep® Buffers, and Non-Porous Silica (NPS).

Eprogen operates through Promigen Life Sciences, Llc.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available